Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesTopiramate in migraine progression
The Journal of Headache and Pain, 10/20/09
Ruiz L et al. – Increasing evidence shows that migraine, typically considered as an episodic disease, is a chronic and, in some patients, progressive disorder. Among neuromodulators used for migraine prevention, topiramate has a high level of evidence–based efficacy. Recent evidence suggests that topiramate, by reducing migraine frequency and use of acute medication, may prevent the negative progression of migraine. Furthermore, two recently completed multicenter, randomised, placebo–controlled trials have shown that treatment with topiramate 100 mg/day is effective and well tolerated in patients already progressed to chronic migraine and difficult to treat conditions associated with medication–overuse. Topiramate seems to be a preventive treatment, which might be able to act at different levels of the migraine cycle: reduction of frequency in episodic migraine, prevention, and treatment of chronic migraine.
Related Articles
Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting
The Journal of Headache and Pain, 11/10/09
Relevance Score: 81%
Topiramate for Migraine Prevention in a Naturalistic Setting: Results From an Open Label, Flexible Dose Study
Headache: The Journal of Head and Face Pain, 10/07/09
Relevance Score: 81%
A Double-Blind Comparison of OnabotulinumtoxinA (BOTOX) and Topiramate (TOPAMAX) for the Prophylactic Treatment of Chronic Migraine: A Pilot Study
Headache: The Journal of Head and Face Pain, 11/05/09
Relevance Score: 80%
Controversies in migraine
Nurse Prescribing, 10/09/09
Relevance Score: 68%
New drugs for migraine
The Journal of Headache and Pain, 10/05/09
Relevance Score: 68%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Zoledronic acid: an unending tale for an antiresorptive agent
Expert Opinion in Pharmacotherapy, 12/11/09
Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease
Expert Opinion in Pharmacotherapy, 12/11/09
Evaluation of Treatment Satisfaction in Children with Allergic Disease Treated with an Antihistamine: An International, Non-Interventional, Retrospective Study
Clinical Drug Investigation, 12/11/09
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Migraine and Functional Impairment
CNS Drugs, 12/11/09
Mediterranean diet and cognitive function in older adults
Current Opinion in Clinical Nutrition & Metabolic Care, 12/11/09
Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer's disease
Phytotherapy Research, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor